{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:27:03Z","timestamp":1792686423714,"version":"4.5.0"},"reference-count":60,"publisher":"Institute of Physiology of the Czech Academy of Sciences","issue":"3\/2025","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Physiol Res"],"abstract":"<jats:p>Pregnant women with type 1 diabetes mellitus (T1DM) are at higher risk of complication development in both mothers and their children. The present study aims to describe changes in circulating and umbilical cord concentrations of recently described predictors of pregnancy complications in a group of women with T1DM. Sixty-seven cases and 34 healthy pregnant controls were included in the study and circulatory levels of TGF-\u03b1, HB-EGF, BDNF, sFlt-4, PDGF, SCF, galectin-1, Fas ligand, CCL-20, P-selectin, IFN\u03b3R1, IL-10, IL-8, leptin, and insulin were assessed in 10 to 13, (V1), 18 to 21 (V2), 28 to 31 (V3) and 34 to 36 weeks of gestation (V4), and immediately after delivery (V5). BDNF, sFlt-4, HB-EGF, SCF, Fas ligand, galectin-1, IL-8, leptin, and insulin were higher in women with T1DM compared to controls during pregnancy (all p&lt;0.05). While HB-EGF, CCL-20, and P-selectin correlate with maternal glucose control, circulatory SCF, P-selectin, galectin-1, PDGF, IFN\u03b3R1, sFlt-4, and TGF-\u03b1 levels positively correlated with IL-10 levels suggesting that their expression is altered in the presence of inflammation. Leptin and insulin cord blood levels were higher in newborns of the mothers with T1DM relative to those without T1DM. Pregnancy of women with type 1 diabetes mellitus is associated with numerous changes in circulatory factors, but these changes are not reflected in the cord blood. The observed variations in trophic and inflammatory mediators may be linked to adverse pregnancy outcomes and could potentially be incorporated into predictive models for pregnancy complications in women with type 1 diabetes.<\/jats:p>","DOI":"10.33549\/physiolres.935424","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T09:18:50Z","timestamp":1753262330000},"page":"403-417","source":"Crossref","is-referenced-by-count":1,"title":["Novel Predictors of Preeclampsia and Pregnancy Complications: the Impact of Type 1 Diabetes Mellitus on Maternal and Fetal Circulatory Levels"],"prefix":"10.33549","author":[{"given":"A","family":"Cinkajzlov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Anderlov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Hornov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Pa\u0159\u00edzek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Mr\u00e1z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Kr\u0161ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Haluz\u00edk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"\u0160imj\u00e1k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"19169","published-online":{"date-parts":[[2025,7,21]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1.\tDiMeglio LA, Evans-Molina C, Oram RA. Type 1 diabetes. Lancet 2018;391:2449-2462. https:\/\/doi.org\/10.1016\/S0140-6736(18)31320-5","DOI":"10.1016\/s0140-6736(18)31320-5"},{"key":"ref1","unstructured":"2.\tVargas R, Repke JT, Ural SH. Type 1 diabetes mellitus and pregnancy. Rev Obstet Gynecol 2010;3:92-100."},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3.\tKirwan JP, Hauguel-De Mouzon S, Lepercq J, Challier JC, Huston-Presley L, Friedman JE, Kalhan SC, Catalano PM. TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes 2002;51:2207-2213. https:\/\/doi.org\/10.2337\/diabetes.51.7.2207","DOI":"10.2337\/diabetes.51.7.2207"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"4.\tPerez-Perez A, Vilarino-Garcia T, Guadix P, Duenas JL, Sanchez-Margalet V. Leptin and Nutrition in Gestational Diabetes. Nutrients 2020;12:1970. https:\/\/doi.org\/10.3390\/nu12071970","DOI":"10.3390\/nu12071970"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5.\tBissonnette F, Cook C, Geoghegan T, Steffen M, Henry J, Yussman MA, Schultz G. Transforming growth factor-\u03b1 and epidermal growth factor messenger ribonucleic acid and protein levels in human placentas from early, mid, and late gestation. Am J Obstet Gynecol 1992;166:192-199. https:\/\/doi.org\/10.1016\/0002-9378(92)91858-8","DOI":"10.1016\/0002-9378(92)91858-8"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6.\tHorowitz GM, Scott RT Jr, Drews MR, Navot D, Hofmann GE. Immunohistochemical localization of transforming growth factor-alpha in human endometrium, decidua, and trophoblast. J Clin Endocrinol Metab 1993;76:786-792. https:\/\/doi.org\/10.1210\/jcem.76.3.7680358","DOI":"10.1210\/jcem.76.3.7680358"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7.\tDao DT, Anez-Bustillos L, Adam RM, Puder M, Bielenberg DR. Heparin-Binding Epidermal Growth Factor-Like Growth Factor as a Critical Mediator of Tissue Repair and Regeneration. Am J Pathol 2018;188:2446-2456. https:\/\/doi.org\/10.1016\/j.ajpath.2018.07.016","DOI":"10.1016\/j.ajpath.2018.07.016"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8.\tIwamoto R, Mekada E. ErbB and HB-EGF signaling in heart development and function. Cell Struct Funct 2006;31:1-14. https:\/\/doi.org\/10.1247\/csf.31.1","DOI":"10.1247\/csf.31.1"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9.\tJessmon P, Leach RE, Armant DR. Diverse functions of HBEGF during pregnancy. Mol Reprod Dev 2009;76:1116-1127. https:\/\/doi.org\/10.1002\/mrd.21066","DOI":"10.1002\/mrd.21066"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10.\tDao DT, Anez-Bustillos L, Adam RM, Puder M, Bielenberg DR. Heparin-Binding Epidermal Growth Factor-Like Growth Factor as a Critical Mediator of Tissue Repair and Regeneration. Am J Pathol 2018;188:2446-2456. https:\/\/doi.org\/10.1016\/j.ajpath.2018.07.016","DOI":"10.1016\/j.ajpath.2018.07.016"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"11.\tBathina S, Das UN. Brain-derived neurotrophic factor and its clinical implications. Arch Med Sci 2015;11:1164-1178. https:\/\/doi.org\/10.5114\/aoms.2015.56342","DOI":"10.5114\/aoms.2015.56342"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12.\tZhang Q, Liu G, Wu Y, Sha H, Zhang P, Jia J. BDNF promotes EGF-induced proliferation and migration of human fetal neural stem\/progenitor cells via the PI3K\/Akt pathway. Molecules 2011;16:10146-10156. https:\/\/doi.org\/10.3390\/molecules161210146","DOI":"10.3390\/molecules161210146"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13.\tPelleymounter MA, Cullen MJ, Wellman CL. Characteristics of BDNF-induced weight loss. Exp Neurol 1995;131:229-238. https:\/\/doi.org\/10.1016\/0014-4886(95)90045-4","DOI":"10.1016\/0014-4886(95)90045-4"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14.\tLapchak PA, Hefti F. BDNF and NGF treatment in lesioned rats: effects on cholinergic function and weight gain. Neuroreport 1992;3:405-408. https:\/\/doi.org\/10.1097\/00001756-199205000-00007","DOI":"10.1097\/00001756-199205000-00007"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15.\tStepan H, Galindo A, Hund M, Schlembach D, Sillman J, Surbek D, Vatish M. Clinical utility of sFlt-1 and PlGF in screening, prediction, diagnosis and monitoring of pre-eclampsia and fetal growth restriction. Ultrasound Obstet Gynecol 2023;61:168-180. https:\/\/doi.org\/10.1002\/uog.26032","DOI":"10.1002\/uog.26032"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"16.\tKaipainen A, Korhonen J, Mustonen T, van Hinsbergh VW, Fang GH, Dumont D, Breitman M, Alitalo K. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci U S A 1995;92:3566-3570. https:\/\/doi.org\/10.1073\/pnas.92.8.3566","DOI":"10.1073\/pnas.92.8.3566"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17.\tPartanen TA, Arola J, Saaristo A, Jussila L, Ora A, Miettinen M, Stacker SA, et al. VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues. FASEB J 2000;14:2087-2096. https:\/\/doi.org\/10.1096\/fj.99-1049com","DOI":"10.1096\/fj.99-1049com"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"18.\tHoch RV, Soriano P. Roles of PDGF in animal development. Development 2003;130:4769-4784. https:\/\/doi.org\/10.1242\/dev.00721","DOI":"10.1242\/dev.00721"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19.\tFredriksson L, Li H, Eriksson U. The PDGF family: four gene products form five dimeric isoforms. Cytokine Growth Factor Rev 2004;15:197-204. https:\/\/doi.org\/10.1016\/j.cytogfr.2004.03.007","DOI":"10.1016\/j.cytogfr.2004.03.007"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20.\tShibuya M. Vascular Endothelial Growth Factor (VEGF) and Its Receptor (VEGFR) Signaling in Angiogenesis: A Crucial Target for Anti- and Pro-Angiogenic Therapies. Genes Cancer 2011;2:1097-1105. https:\/\/doi.org\/10.1177\/1947601911423031","DOI":"10.1177\/1947601911423031"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21.\tKauma S, Huff T, Krystal G, Ryan J, Takacs P, Turner T. The expression of stem cell factor and its receptor, c-kit in human endometrium and placental tissues during pregnancy. J Clin Endocrinol Metab 1996;81:1261-1266. https:\/\/doi.org\/10.1210\/jcem.81.3.8772609","DOI":"10.1210\/jcem.81.3.8772609"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22.\tBroudy VC. Stem Cell Factor and Hematopoiesis. Blood 1997;90:1345-1364. https:\/\/doi.org\/10.1182\/blood.V90.4.1345","DOI":"10.1182\/blood.v90.4.1345.1345_1345_1364"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"23.\tJohannes L, Jacob R, Leffler H. Galectins at a glance. J Cell Sci 2018;131:jcs208884. https:\/\/doi.org\/10.1242\/jcs.208884","DOI":"10.1242\/jcs.208884"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24.\tJovanovi\u0107 Krivoku\u0107a M, Viloti\u0107 A, Nacka-Aleksi\u0107 M, Pirkovi\u0107 A, \u0106uji\u0107 D, Legner J, Dekanski D, Boji\u0107-Trbojevi\u0107 \u017d. Galectins in Early Pregnancy and Pregnancy-Associated Pathologies. Int J Mol Sci 2021;23:69. https:\/\/doi.org\/10.3390\/ijms23010069","DOI":"10.3390\/ijms23010069"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25.\tBlois SM, Barrientos G. Galectin signature in normal pregnancy and preeclampsia. J Reprod Immunol 2014;101-102:127-134. https:\/\/doi.org\/10.1016\/j.jri.2013.05.005","DOI":"10.1016\/j.jri.2013.05.005"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"26.\tWu MH, Ying NW, Hong TM, Chiang WF, Lin YT, Chen YL. Galectin-1 induces vascular permeability through the neuropilin-1\/vascular endothelial growth factor receptor-1 complex. Angiogenesis 2014;17:839-849. https:\/\/doi.org\/10.1007\/s10456-014-9431-8","DOI":"10.1007\/s10456-014-9431-8"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"27.\tYu X, Qian J, Ding L, Yin S, Zhou L, Zheng S. Galectin-1: A Traditionally Immunosuppressive Protein Displays Context-Dependent Capacities. Int J Mol Sci 2023;24:6501. https:\/\/doi.org\/10.3390\/ijms24076501","DOI":"10.3390\/ijms24076501"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"28.\tNagata S, Golstein P. The Fas death factor. Science 1995;267:1449-1456. https:\/\/doi.org\/10.1126\/science.7533326","DOI":"10.1126\/science.7533326"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"29.\tDeFranco S, Bonissoni S, Cerutti F, Bona G, Bottarel F, Cadario F, Brusco A, et al. Defective Function of Fas in Patients With Type 1 Diabetes Associated With Other Autoimmune Diseases. Diabetes 2001;50:483-488. https:\/\/doi.org\/10.2337\/diabetes.50.3.483","DOI":"10.2337\/diabetes.50.3.483"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"30.\tHamad AR, Arcara K, Uddin S, Donner T. The potential of Fas ligand (apoptosis-inducing molecule) as an unconventional therapeutic target in type 1 diabetes. Front Immunol 2012;3:196. https:\/\/doi.org\/10.3389\/fimmu.2012.00196","DOI":"10.3389\/fimmu.2012.00196"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"31.\tYolcu ES, Shirwan H, Askenasy N. Fas\/Fas-Ligand Interaction As a Mechanism of Immune Homeostasis and \u03b2-Cell Cytotoxicity: Enforcement Rather Than Neutralization for Treatment of Type 1 Diabetes. Front Immunol 2017;8:342. https:\/\/doi.org\/10.3389\/fimmu.2017.00342","DOI":"10.3389\/fimmu.2017.00342"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"32.\tZheng Z, Zheng F. A complex auxiliary: IL-17\/Th17 signaling during type 1 diabetes progression. Mol Immunol 2019;105:16-31. https:\/\/doi.org\/10.1016\/j.molimm.2018.11.007","DOI":"10.1016\/j.molimm.2018.11.007"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"33.\tZiegler D, Strom A, B\u00f6nhof GJ, Kannenberg JM, Heier M, Rathmann W, Peters A, et al. Deficits in systemic biomarkers of neuroinflammation and growth factors promoting nerve regeneration in patients with type 2 diabetes and polyneuropathy. BMJ Open Diabetes Res Care 2019;7:e000752. https:\/\/doi.org\/10.1136\/bmjdrc-2019-000752","DOI":"10.2337\/db18-63-or"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"34.\tChu X, Jin Q, Chen H, Wood GC, Petrick A, Strodel W, Gabrielsen J, et al. CCL20 is up-regulated in non-alcoholic fatty liver disease fibrosis and is produced by hepatic stellate cells in response to fatty acid loading. J Transl Med 2018;16:108. https:\/\/doi.org\/10.1186\/s12967-018-1490-y","DOI":"10.1186\/s12967-018-1490-y"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"35.\tAndr\u00e9 P, Hartwell D, Hrachovinov\u00e1 I, Saffaripour S, Wagner DD. Pro-coagulant state resulting from high levels of soluble P-selectin in blood. Proc Natl Acad Sci U S A 2000;97:13835-13840. https:\/\/doi.org\/10.1073\/pnas.250475997","DOI":"10.1073\/pnas.250475997"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"36.\tJilma B, Fasching P, Ruthner C, Rumplmayr A, Ruzicka S, Kapiotis S, Wagner OF, Eichler HG. Elevated circulating P-selectin in insulin dependent diabetes mellitus. Thromb Haemost 1996;76:328-332. https:\/\/doi.org\/10.1055\/s-0038-1650578","DOI":"10.1055\/s-0038-1650578"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"37.\tSchroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-\u03b3: an overview of signals, mechanisms and functions. J Leukoc Biol 2004;75:163-189. https:\/\/doi.org\/10.1189\/jlb.0603252","DOI":"10.1189\/jlb.0603252"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"38.\tChen LJ, Gao H, Zhou H, Zou L, Zou P. Contribution of interferon-gamma receptor 1 gene polymorphisms to pre-eclampsia in China. Am J Reprod Immunol 2010;63:331-338. https:\/\/doi.org\/10.1111\/j.1600-0897.2009.00801.x","DOI":"10.1111\/j.1600-0897.2009.00801.x"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"39.\tSokolov D, Onohina Y, Mikhaylova V, Ovchinnikova O, Korenkov D, Selkov S. Immune cells functional disorder in case of preeclampsia. Front Immunol 2013;4. https:\/\/doi.org\/10.3389\/conf.fimmu.2013.02.00782","DOI":"10.3389\/conf.fimmu.2013.02.00782"},{"key":"ref39","unstructured":"40.\tBickel M. The role of interleukin-8 in inflammation and mechanisms of regulation. J Periodontol 1993;64(5 Suppl):456-460."},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"41.\tMosser DM, Zhang X. Interleukin-10: new perspectives on an old cytokine. Immunol Rev 2008;226:205-218. https:\/\/doi.org\/10.1111\/j.1600-065X.2008.00706.x","DOI":"10.1111\/j.1600-065X.2008.00706.x"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"42.\tBriana DD, Liosi S, Gourgiotis D, Boutsikou M, Marmarinos A, Baka S, Hassiakos D, Malamitsi-Puchner A. Fetal concentrations of the growth factors TGF-\u03b1 and TGF-\u03b21 in relation to normal and restricted fetal growth at term. Cytokine 2012;60:157-161. https:\/\/doi.org\/10.1016\/j.cyto.2012.06.005","DOI":"10.1016\/j.cyto.2012.06.005"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"43.\tKacarevic D, Bogavac-Stanojevic N, Spasojevic-Kalimanovska V, Bojanin D, Milenkovic T, Stefanovic A, Mihajlovic M, et al. Heparin-binding epidermal growth factor (EGF)-like growth factor in pediatric patients with type 1 diabetes mellitus. Growth Factors 2020;38:120-126. https:\/\/doi.org\/10.1080\/08977194.2020.1841757","DOI":"10.1080\/08977194.2020.1841757"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"44.\tUttarwar L, Peng F, Wu D, Kumar S, Gao B, Ingram AJ, Krepinsky JC. HB-EGF release mediates glucose-induced activation of the epidermal growth factor receptor in mesangial cells. Am J Physiol Renal Physiol 2011;300:F921-F931. https:\/\/doi.org\/10.1152\/ajprenal.00436.2010","DOI":"10.1152\/ajprenal.00436.2010"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"45.\tKim S, Subramanian V, Abdel-Latif A, Lee S. Role of Heparin-Binding Epidermal Growth Factor-Like Growth Factor in Oxidative Stress-Associated Metabolic Diseases. Metab Syndr Relat Disord 2020;18:186-196. https:\/\/doi.org\/10.1089\/met.2019.0120","DOI":"10.1089\/met.2019.0120"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"46.\tRozanska O, Uruska A, Zozulinska-Ziolkiewicz D. Brain-Derived Neurotrophic Factor and Diabetes. Int J Mol Sci 2020;21:841. https:\/\/doi.org\/10.3390\/ijms21030841","DOI":"10.3390\/ijms21030841"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"47.\tChristian LM, Mitchell AM, Gillespie SL, Palettas M. Serum brain-derived neurotrophic factor (BDNF) across pregnancy and postpartum: Associations with race, depressive symptoms, and low birth weight. Psychoneuroendocrinology 2016;74:69-76. https:\/\/doi.org\/10.1016\/j.psyneuen.2016.08.025","DOI":"10.1016\/j.psyneuen.2016.08.025"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"48.\tDuan W, Guo Z, Jiang H, Ware M, Mattson MP. Reversal of behavioral and metabolic abnormalities, and insulin resistance syndrome, by dietary restriction in mice deficient in brain-derived neurotrophic factor. Endocrinology 2003;144:2446-2453. https:\/\/doi.org\/10.1210\/en.2002-0113","DOI":"10.1210\/en.2002-0113"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"49.\tBriana DD, Papastavrou M, Boutsikou M, Marmarinos A, Gourgiotis D, Malamitsi-Puchner A. Differential expression of cord blood neurotrophins in gestational diabetes: the impact of fetal growth abnormalities. J Matern Fetal Neonatal Med 2018;31:278-283. https:\/\/doi.org\/10.1080\/14767058.2017.1281907","DOI":"10.1080\/14767058.2017.1281907"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"50.\tGuillausseau PJ, Dupuy E, Bryckaert MC, Timsit J, Chanson P, Tobelem G, Caen JP, Lubetzki J. Platelet-derived growth factor (PDGF) in type 1 diabetes mellitus. Eur J Clin Invest 1989;19:172-175. https:\/\/doi.org\/10.1111\/j.1365-2362.1989.tb00213.x","DOI":"10.1111\/j.1365-2362.1989.tb00213.x"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"51.\tFryk E, Silva VRR, Jansson P-A. Galectin-1 in Obesity and Type 2 Diabetes. Metabolites 2022;12:930. https:\/\/doi.org\/10.3390\/metabo12100930","DOI":"10.3390\/metabo12100930"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"52.\tTirado-Gonz\u00e1lez I, Freitag N, Barrientos G, Shaikly V, Nagaeva O, Strand M, Kjellberg L, et al. Galectin-1 influences trophoblast immune evasion and emerges as a predictive factor for the outcome of pregnancy. Mol Hum Reprod 2013;19:43-53. https:\/\/doi.org\/10.1093\/molehr\/gas043","DOI":"10.1093\/molehr\/gas043"},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"53.\tHasan S, Alshaikh B, Yusuf K. Serum levels of soluble Fas and Fas ligand in pregnant women who smoke. Am J Reprod Immunol 2021;85:e13382. https:\/\/doi.org\/10.1111\/aji.13382","DOI":"10.1111\/aji.13382"},{"key":"ref53","doi-asserted-by":"publisher","unstructured":"54.\tAyala-Ram\u00edrez P, Machuca-Acevedo C, G\u00e1mez T, Quijano S, Barreto A, Silva JL, Olaya CM, Garc\u00eda-Robles R. Assessment of Placental Extracellular Vesicles-Associated Fas Ligand and TNF-Related Apoptosis-Inducing Ligand in Pregnancies Complicated by Early and Late Onset Preeclampsia. Front Physiol 2021;12:708824. https:\/\/doi.org\/10.3389\/fphys.2021.708824","DOI":"10.3389\/fphys.2021.708824"},{"key":"ref54","doi-asserted-by":"publisher","unstructured":"55.\tKauma SW, Huff TF, Hayes N, Nilkaeo A. Placental Fas ligand expression is a mechanism for maternal immune tolerance to the fetus. J Clin Endocrinol Metab 1999;84:2188-2194. https:\/\/doi.org\/10.1210\/jc.84.6.2188","DOI":"10.1210\/jcem.84.6.5730"},{"key":"ref55","doi-asserted-by":"publisher","unstructured":"56.\tHongyu Q, Yongyu S, Liping H. Study on the expression of fas ligand on the surfaces of human cytotrophoblasts in normal pregnancy. J Tongji Med Univ 2000;20:166-168. https:\/\/doi.org\/10.1007\/BF02887063","DOI":"10.1007\/bf02887063"},{"key":"ref56","doi-asserted-by":"publisher","unstructured":"57.\tOh SY, Park JC, Kwon SH, Cho CH, Rhee JH, Cha SD, Yoon SD, Kim JI. Maternal serum soluble Fas\/Fas ligand level and expression of Fas\/Fas ligand in placenta in preeclampsia. Korean J Obstet Gynecol 2006;49:520-526.","DOI":"10.1111\/j.1365-2133.2005.07057.x"},{"key":"ref57","doi-asserted-by":"publisher","unstructured":"58.\tKarowicz-Bili\u0144ska A, Kowalska-Koprek U, Estemberg D, Sikora-Szubert A. Evaluation of soluble concentration Fas and Fas ligand in maternal and cord blood 3rd trimester of pregnancy. Ginekol Pol 2018;89:142-146. https:\/\/doi.org\/10.5603\/GP.a2018.0024","DOI":"10.5603\/gp.a2018.0024"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"59.\tYngen M, \u00d6stenson CG, Hu H, Li N, Hjemdahl P, Wall\u00e9n NH. Enhanced P-selectin expression and increased soluble CD40 Ligand in patients with Type 1 diabetes mellitus and microangiopathy: evidence for platelet hyperactivity and chronic inflammation. Diabetologia 2004;47:537-540. https:\/\/doi.org\/10.1007\/s00125-004-1352-4","DOI":"10.1007\/s00125-004-1352-4"},{"key":"ref59","doi-asserted-by":"publisher","unstructured":"60.\tLaskowska M, Laskowska K, Oleszczuk J. Elevated maternal serum sP-selectin levels in preeclamptic pregnancies with and without intrauterine fetal growth restriction, but not in normotensive pregnancies complicated by isolated IUGR. Med Sci Monit 2013;19:118-124. https:\/\/doi.org\/10.12659\/MSM.883780","DOI":"10.12659\/msm.883780"}],"container-title":["Physiological Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T09:19:03Z","timestamp":1753262343000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.biomed.cas.cz\/physiolres\/pdf\/2025\/74_403.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,21]]},"references-count":60,"journal-issue":{"issue":"3\/2025","published-online":{"date-parts":[[2025,7,21]]}},"URL":"https:\/\/doi.org\/10.33549\/physiolres.935424","relation":{},"ISSN":["1802-9973","0862-8408"],"issn-type":[{"value":"1802-9973","type":"electronic"},{"value":"0862-8408","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,21]]}}}